Feline leukemia virus (FeLV) is horizontally transmitted in the domestic cat population and is known to be the etiological agent of feline lymphosarcoma, as well as of a large variety of other feline diseases. Several replicationdefective v-myc-containing feline retroviruses have been characterized in feline lymphosarcoma. From FeLVassociated feline fibrosarcomas, in contrast, acute transforming retroviruses (ATVs) containing a variety of oncogenes have been isolated and characterized (5, 76) . Six different v-onc genes, v-fes(fps), v-fms, v-sis, v-abl, v-fgr, and v-kit have been found in the nine known virus strains, ST-, GA-, SM-, GR-, PI-, HZ1-, HZ2-, TPi-and HZ4-feline sarcoma virus (FeSV) (7, 7a, 8, 18, 19, 25, 30, 41, 49, 54, 66, 67, 79) . Our past characterization of the PI-, HZ2-, and HZ4-FeSVs indicated that there is no apparent specificity for the transduction of c-onc genes by FeLV in viruses recovered from fibrosarcomas. We therefore have continued to isolate and characterize new oncogene-containing feline retroviruses in order to explore further the repertoire of oncogenes that may be found in such viruses. We describe here the isolation and characterization of the HZ5-FeSV, a new feline ATV with v-fms homology.
The SM-FeSV originated by the transduction of feline c-fms sequences by FeLV (16, 19, 41) . The genetic structure of the SM-FeSV is 5 ' A gag-ftns-env 3'. The v-fms amino acid sequence displays features characteristic of a transmembrane receptor, and the cytoplasmic domain of v-fms shows homology with tyrosine-specific protein kinases (24). In the SM-FeSV, v-fms is expressed as a gag-fusion protein which is processed to become a transmembrane (11, 48) . A summary of the onc plasmids used in this study is shown in Table 1 .
DNA transfections. DNA transfections were done essentially as described previously (27) . Various amounts of cloned DNA (1 to 100 ng) were added to 30 ,ug of sheared NIH 3T3 carrier DNA and then precipitated with ethanol. The precipitated DNA was suspended in 1.25 ml of transfection buffer and then precipitated slowly by the addition of 2 M CaCI2. The precipitate suspension (0.6 ml) was added to 3.5 ml of medium in a 6-cm dish previously seeded with 4 x i05 NIH 3T3 cells, and after 4 h the cultures were treated for 4 min with 15% glycerol in phosphate-buffered saline. At 12 to 16 h after addition of the DNA the cells were reseeded at picked using glass cloning cylinders and grown to mass culture.
DNA sequence analysis. Nucleic acid sequences were determined by the chain determination method of Sanger et al. after fragments were subcloned into the phage M13 vectors mpl8 and mpl9 (59, 78) .
RESULTS
Origin of HZ5-FeSV. A 3.5-year-old male domestic cat (SKI 3674) with multiple fibrosarcomas was obtained from a pet household in West Palm Beach, Fla. Nodules had been observed for 5 months in subcutaneous tissues; upon autopsy nodules were present in the ventral aspect of the tail (one), the lateral aspect of the ventral chest (four), and the ventral abdominal muscles (one). No metastatic lesions were found in the thoracic or abdominal viscera. The cat was infected with FeLV, as indicated by the presence of FeLV antigens in peripheral blood leukocytes (61) Extract obtaine4 from one tu'mor node in the abdominal muscles was used to infect Fea feline embryo fibroblasts. These cells assumed a predominantly transformed phenotype upon passage, indicating the presence of a transforming virus. To obtain HZ5-FeSV pseudotype virus with an extended host range, the Fea/3674-3 cells were infected with amph-MuLV. A filtered virus stock obtained from the amphMuLV-infected Fea/3674-3 cells was then used to infect rat FRE-3A cells in a standard focus assay. After 7 to 10 days, foci of transformed cells were discernible, and after 11 days individual foci were picked with cloning cylinders, grown up to mass culture, and subsequently cloned twice in semisolid medium. Two of these transformants, the FRE 3674-3/C1SB1 cells, were virus nonproducers, i.e., they did not release infectious virus particles. Superinfection of these cells with amph-MuLV produced 102 to 103 focus-forming units (FFU)/ml of HZ5-FeSV, as determined by focus assay, and 105 FFU/ml of amph-MuLV helper virus. Foci of transformed cells were observed on Fea cat, CCL64 mink, FRE-3A rat, and NIH 3T3 mnouse cells (see Fig. 3 ). These experiments provide evidence for the replication-defective nature of the HZ5-FeSV. The FRE HZ5-FeSV nonproducer cells display features characteristic of transformation, i.e., they grow in semisolid medium and produce fibrosarcomas in nude mice.
Structure of the flZ5-FeSV genome. We first investigated the structure of the integrated HZ5-FeSV genome in HZ5-FeSV-infected mink and rat FRE-3A cells by Southern blot analysis. These experiments indicated that the HZ5-FeSV genome did not contain any EcoRI restriction sites. The DNA from rat FRE and mink HZ5-FeSV nonproducer cells had EcoRI restriction fragments of 14 and >25 kb, respectively, which contained the HZ5-FeSV provirus as determined by hybridization with an FeLV rep probe. We have cloned the 14-kb EcoRI fragment from the FRE rat HZ5-FeSV nonproducer cell DNA using the lambda vector L47.1 to determine the structure of the HZ5-FeSV provirus. A resctriction map of the integrated HZ5-FeSV provirus is shown in Fig. 1 Restriction map and genetic structure of the molecularly cloned HZ5-FeSV provirus. The restriction enzymes used to construct this map were EcoRI (R), HindlIl (H), Sacl (Sc), SmaI (Sm), KpnI (K), Bglll (Bg), BamHl (B), XhoI (X), and HpaI (Hp).
of sites at the 3' end of the pol sequences-SmaI, KpnI, BamHI, and XhoI at 9.2, 9.5, 9.8, and 10.4 kb, respectively-are found.
A 1.4-kb Sacl fragment (7.5 to 8.9 kb) was found to lack homology with FeLV sequences (Fig. 2C , lane 2). A 2.7-kb HpaI-SmaI fragment (6.5 to 9.2 kb), on the other hand, showed hybridization with FeT-V sequences. These results indicate that the 1.4-kb SacI fragment is part of the HZ5-FeSV-specific sequences and, assuming that the H,paI site at 6.5 kb is within the HZ5-FeSV-specific sequences (see below), they also indicate that the 3' breakpoint of these sequences is between the Sacl and SmaI sites at 8.9 and 9.2 kb.
The biological activity of the cloned HZ5-FeSV provirus was investigated by DNA transfection experiments. NIH 3T3 mouse cells were transfected with pHZ5 DNA by the calcium phosphate precipitation procedure (22). The appearance of foci of transformed cells was dose dependent, and the efficiency was approximately 104 FFU/pmol ( Table 2) . Foci of transformed cells were picked and grown for analysis. Focus-forming virus could be obtained readily from the transformed cell lines upon superinfection with amph-MuLV HZ5-FeSV shows v-fms sequence homology. The relationship of the HZ5-FeSV-specific sequences with that of the known oncogenes was then investigated. Recombinant plasmids containing the different retroviral oncogenes were digested with restriction enzymes to obtain fragments which contained v-onc sequences free of helper-virus sequences (Table 1) . Southern blots containing these DNAs were hybridized with a hybridization probe obtained from the 14-kb insert of the HZ5-FeSV plasmid, and hybridization was carried out at low stringency to detect cross-species homologies due to the different origins of the oncogenes used in this study (Fig. 4) . The HZ5-FeSV provirus was found to hybridize to the 1.6-kb KpnI-BgIII v-fms fragment, as well as with FeLV and other mammalian helper retrovirus sequences (Fig. 4B) . No hybridization was seen with restriction fragments containing h-ras, k-ras, n-ras, src, yes, ros, abl, and fes (Fig. 4) or containing myc, myb, ski, fos, sis, raf, rel, erbAB, and mos (data not shown). These results demonstrate that the HZ5-FeSV provirus contained sequences homologous to the v-fms sequences of the SM-FeSV. The v-fms sequences in the two viruses appear to be of similar origin (the domestic cat) since the hybridization signal was retained upon washing in 0.2x SSC at 65°C (Fig. 4, panel C) .
Comparative analysis of the v-fms sequences in the HZ5-and the SM-FeSVs. To identify the v-fms sequences in the HZ5-FeSV genome, DNA blots containing HZ5-FeSV DNA were hybridized with a v-fms hybridization probe. These experiments indicated that the v-fms sequences in the HZ5-FeSV are located between the HpaI site at 6.5 kb and the SacI site at 8.9 kb of the HZ5-FeSV restriction map ( In the HZ5-FeSV the known open reading frame of v-fms extends from the BglII site (nucleotide 1) to nucleotide 162 (Fig. 5) , where a TGA termination signal is reached. The predicted C terminus of the HZ5-FeSV v-fms gene product, on the other hand, contains 11 amino acids which are present in the HZ5-FeSV. DISCUSSION Similar origins and structures of HZ5-and SM-FeSV. HZ5-FeSV and SM-FeSV were both isolated from multicentric fibrosarcomas of domestic cats; the morphology of cells transformed by them is indistinguishable (Fig. 3) , and both viruses were similarly generated by the transduction of feline c-fms sequences with FeLV. Our (Fig. 4B ) and at 65°C (Fig. 4C) . Ethidium bromide-stained gels before the transfer are shown in Fig. 4A . Restriction fragments containing v-onc sequences are marked by a white asterisk. The v-onc DNAs pHEE6 (v-h-ras), pHiHi3 (v-k-ras), pnras (n-ras), psrc (v-src), lambda Y73-IIA (v-yes), pros (v-ros), pAB3sub3 (v-abl), pl30abl (v-abl), pvfes (v-fes), and pSMFeSV (v-fms) were digested with the restriction enzymes indicated in Table 1 . The FeLV plasmid pGAFeLV was digested with KpnI. Lambda DNA digested with HindlIl is shown in lane 13. SM-FeSV recombination sites in FeLV plO. The known site in plO was used twice although a similar recombination, in which the gag reading frame is sustained, is possible in the p30 region (amino acid 445 of FeLV gag).
The nucleotide sequence of the recently characterized hupian c-fms cDNA shows that there is an 8-base homology between the c-fms and the FeLV gag sequences at the 5' recombination site in the HZ5-and SM-FeSVs (13a). Unless functional constraints for the expression of the transforming protein are determining the recombination event, this finding suggests that short sequence homologies at retroviral recombination sites are a determining factor in the generation of retrovirus v-onc junctions. These observations are in good agreement with those known from procaryotes where short sequence homologies determine hot spots for deletion formation (1). Both HZ5-FeSV and SM-FeSV v-fms are C-terminally truncated versions of c-fms. The protein product of the protooncogene c-fms, M-CSFR, is an integral transmembrane receptor with an outer cellular domain (ligand-binding domain), a transmembrane domain, and an intracellular domain (24, 56, 57, 65). The intracellular domain contains the protein kinase which is activated upon ligand binding. In analogy with other receptor systems, the activation of the M-CSFR kinase is thought to be an essential step in M-CSF-mediated signal transduction (56, 65) . The human c-fms cDNA nucleotide sequence predicts that the c-fms sequences at the 5' junction of both HZ5-and SM-FeSV derive from the 5'-untranslated region of c-fms, such that the gag open reading frame is sustained through the untranslated region into the correct reading frame of c-fms (13a) . As a result, the v-fms gene product of the HZ5-and SM-FeSVs is predicted to contain the entire outer cellular domain of the feline M-CSF receptor.
At the C terminus the HZ5-FeSV and SM-FeSV differ. We have compared the HZ5-FeSV 3' v-fms sequence with the 3' human c-fms cDNA sequence in order to determine their relationship (Fig. 6) (13a) . The two sequences are clearly related, although differences do exist. The most striking feature is an 11-bp deletion of c-fms sequences in v-fms at nucleotide 155 (Fig. 5) . As a result of this frameshift mutation, a TGA termination signal is reached two amino acids downstream. We therefore predict that the HZ5-FeSV v-fms protein is missing the 24 C-terminal amino acids of feline c-fms. In contrast, comparison of the 3' SM-FeSV v-fms sequences with c-fms and HZ5-FeSV v-fms revealed no relationship. The origin of these sequences is not known; they could derive either from downstream sequences of the c-fms locus or possibly from sequences of another locus. In the SM-FeSV v-fms protein, as a consequence of the sequence insertion in SM-FeSV v-fms, a 48-amino-acid segment at the C terminus of the c-fms protein is replaced by a sequence of 11 amino acids of unknown origin.
At the point where HZ5-FeSV and SM-FeSV v-fms sequences diverge a unique repeat sequence (AGC)x is found. In the HZ5-FeSV the (AGC)11 segment is furthermore followed by a 33-nucleotide sequence which very likely derives from the same AGC repeat unit. -plO -----A--------------------C ------A-C ---------A----------- pl(J-4-I-start v-fms 
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A are known to facilitate the generation of deletions and amplifications (1) . It is therefore likely that the polymorphism seen between the feline and the humanfms sequences is based on the repeated nature of these sequences.
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Protein kinase oncogenes like src and erbB (EGFR) are thought to derive their oncogenic properties from structural alterations of their protein products rather than from a disruption of the mode of expression as is observed with "nuclear oncogenes" such as myc, myb, and fos (9, 29, 35, 43, 52, 62, 71) . The v-erbB protein of AEV-H is a truncated version of EGFR in which N-terminal and C-terminal sequences are missing (72, 77) . In avian leukosis virus-induced erythroblastosis, EGFR is truncated at the N-terminus only (34, 51) . Both src and EGFR contain in their C-terminal domains important tyrosine phosphorylation sites, which are known to contribute to the modulation of their respective associated protein kinase activities (13, 23) . Both HZ5-and SM-FeSVs have truncated C termini, and it seems possible that this alteration is a determinant of the oncogenic properties of the two v-fms proteins. An alternative mechanism of the transformation mediated by v-fms has recently been proposed by Sherr et al. (65) . Fibroblasts, as well as a number of other tissues, are known to produce M-CSF. Since v-fms contains the entire outer cellular domain of the M-CSF receptor, it is feasible that M-CSF could bind to the v-fms protein in HZ5-FeSV-or SM-FeSV-infected cells and thus establish an autocrine loop. HZ5-FeSV and SM-FeSV readily transform nonfeline mammalian cells; if the proposed autocrine mechanism is true then M-CSF should display cross-species reactivity that parallels the transformation specificity of the fms viruses. Single-amino-acid differences between the SM-FeSV v-fms protein and the human c-fms proteins exist, particularly in the extracellular domain. These could be species differences; however, they may also be activating mutations. A critical evaluation of amino acid differences between the v-fms proteins and the human and cat c-fms proteins may therefore be necessary in order for us to understand the oncogenic activation of v-fms. High-frequency cotransfer of the transformed phenotype and tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice.
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